6533b85afe1ef96bd12b980a

RESEARCH PRODUCT

Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study

Ulf ZiemannMarkus PlonerAchim BertheleTania KümpfelS. NischwitzBrigitte WildemannSergiu GroppaHayrettin TumaniChristoph HeesenBernhard HemmerLuisa KlotzSven G. MeuthFelix LuessiSarah HaarsAnke SalmenMark MühlauRalf A. LinkerHans-peter HartungSusanna AsseyerFrauke ZippHenrik HeitmannHeinz WiendlBjörn AmbrosiusRalf GoldUwe K. ZettlLaura TiemannThomas R. TölleBjörn TackenbergBernhard HallerAntonios BayasMartin Stangel

subject

Biopsychosocial modelmedicine.medical_specialtyMultiple SclerosisCohort Studies03 medical and health sciences0302 clinical medicine030202 anesthesiologyInternal medicineEpidemiologyPrevalenceHumansMedicineProspective StudiesProspective cohort study610 Medicine & healthFatigueDepression (differential diagnoses)Clinically isolated syndromeDepressionbusiness.industryMultiple sclerosismedicine.diseaseAnesthesiology and Pain MedicineNeurologyNeuropathic painNeurology (clinical)business030217 neurology & neurosurgeryCohort study

description

Pain is frequent in multiple sclerosis (MS) and includes different types, with neuropathic pain (NP) being most closely related to MS pathology. However, prevalence estimates vary largely, and causal relationships between pain and biopsychosocial factors in MS are largely unknown. Longitudinal studies might help to clarify the prevalence and determinants of pain in MS. To this end, we analyzed data from 410 patients with newly diagnosed clinically isolated syndrome or relapsing-remitting MS participating in the prospective multicenter German National MS Cohort Study (NationMS) at baseline and after 4 years. Pain was assessed by self-report using the PainDETECT Questionnaire. Neuropsychiatric assessment included tests for fatigue, depression, and cognition. In addition, sociodemographic and clinical data were obtained. Prevalence of pain of any type was 40% and 36% at baseline and after 4 years, respectively, whereas prevalence of NP was 2% and 5%. Pain of any type and NP were both strongly linked to fatigue, depression, and disability. This link was even stronger after 4 years than at baseline. Moreover, changes in pain, depression, and fatigue were highly correlated without any of these symptoms preceding the others. Taken together, pain of any type seems to be much more frequent than NP in early nonprogressive MS. Moreover, the close relationship between pain, fatigue, and depression in MS should be considered for treatment decisions and future research on a possible common pathophysiology.

10.1097/j.pain.0000000000001767https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/77315